000739:SHE
Apeloa Pharmaceutical Co Ltd
23,42 CNY
arrow_downward
-1,64%(-0,39) 1 d.
16. 10., 15:04:48 GMT+8 · CNY
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre 000739…
Otvoriť
24,04 CNY
Vysoká
24,76 CNY
Nízka
23,09 CNY
Trh. kap.
27,13 mld.
Priem. obj.
16,27 mil.
Objem
15,09 mil.
Dividenda
1,61 %
Štvrťročná dividenda
0,09 CNY
Prvý obchodný deň po vyplatení dividendy
8. 10. 2026
Pomer cena/zárobky
31,78
Max. za 52 týž.
28,50 CNY
Min. za 52 týž.
14,89 CNY
Výnosy na akciu
0,74 CNY
Akcie v obehu
1,16 mld.
Počet zamestnancov
7 tis.
Otvoriť
24,04 CNY
Vysoká
24,76 CNY
Nízka
23,09 CNY
Trh. kap.
27,13 mld.
Priem. obj.
16,27 mil.
Objem
15,09 mil.
Dividenda
1,61 %
Štvrťročná dividenda
0,09 CNY
Prvý obchodný deň po vyplatení dividendy
8. 10. 2026
Pomer cena/zárobky
31,78
Max. za 52 týž.
28,50 CNY
Min. za 52 týž.
14,89 CNY
Výnosy na akciu
0,74 CNY
Akcie v obehu
1,16 mld.
Počet zamestnancov
7 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
GlobeNewswire
·
pred 58 minútami
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
www.marketscreener.com
·
pred 14 minútami
Inter & Co, Inc.(NasdaqGS: INTR) added to S&P Global BMI Index
FXLeaders
·
pred 17 minútami
Nasdaq and Dow Futures Recover Ealy Monday Ahead of Meta, Tesla and SpaceX Earnings as Iran De-escalation Hopes Lift Sentiment
Bloomberg.com
·
pred 2 hodinami
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Informácie o subjekte Apeloa Pharmaceutical Co Ltd